Offer - Urjas Oil for just ₹ 1
Iminoral 25 Capsule is a prescription drug, available for use as Capsule. It is typically used for the treatment of Psoriasis, Liver transplant. Secondary and off-label uses of Iminoral 25 Capsule have also been mentioned below.
The correct dosage of Iminoral 25 Capsule depends on the patient's age, gender, and medical history. Individual symptoms and route of administration also determines the right dosage. This information has been provided in detail in the dosage section.
The most common side effects of Iminoral 25 Capsule are Increased hair growth, Loss of appetite. Apart from the aforementioned side effects, Iminoral 25 Capsule can also lead to other problems, which have been listed below. These side effects of Iminoral 25 Capsule are usually temporary and subside with the completion of treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
In addition, Iminoral 25 Capsule's effect is Unknown during pregnancy and Severe for lactating mothers. In addition, Iminoral 25 Capsule's effects on the liver, heart and kidney are discussed below in the Iminoral 25 Capsule related warnings section.
Individuals suffering from medical conditions like Liver Disease must refrain from the use of Iminoral 25 Capsule since this can cause severe adverse effects. Other contraindications of Iminoral 25 Capsule have been discussed in the sections ahead.
Drug interactions for Iminoral 25 Capsule have been reported in the medical literature. A complete list of these interactions is given below.
You should also be aware that Iminoral 25 Capsule is safe while driving, and is addiction.
Iminoral 25 Capsule is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
Is the use of Iminoral 25 Capsule safe for pregnant women?
No research has not been done till date on the safety of Iminoral for pregnant women. So its effects on pregnant women are unknown.
Is the use of Iminoral 25 Capsule safe during breastfeeding?
Taking Iminoral may lead to serious side effects if you are breastfeeding. Iminoral should not be taken by breastfeeding women unless prescribed by the doctor.
What is the effect of Iminoral 25 Capsule on the Kidneys?
Iminoral has very mild side effects on the kidneys.
What is the effect of Iminoral 25 Capsule on the Liver?
Very few cases of side effects of Iminoral on the liver have been reported.
What is the effect of Iminoral 25 Capsule on the Heart?
Side effects of Iminoral rarely affect the heart.
If you are suffering from any of the following diseases, you should not take Iminoral 25 Capsule unless your doctor advises you to do so -
Is this Iminoral 25 Capsule habit forming or addictive?
Iminoral 25 Capsule does not cause addiction.
Is it safe to drive or operate heavy machinery when consuming?
Iminoral 25 Capsule will not make you feel sleepy or drowsy. So you drive or operate machinery safely.
Is it safe?
Yes, but consume Iminoral 25 Capsule only on doctor's advice.
Is it able to treat mental disorders?
No, Iminoral 25 Capsule is not used to treat mental disorders.
Interaction between Food and Iminoral 25 Capsule
When consumed with certain foods, Iminoral 25 Capsule may take longer to have an effect. Contact your doctor about this.
Interaction between Alcohol and Iminoral 25 Capsule
Consuming Iminoral 25 Capsule with alcohol can have many serious effects on your body.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Sandimmune® (cyclosporine)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 876-881
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 377-380
